menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

THERAPY CELLS INC (TCEL)
0.0001 0 (0%)  11-22 15:10
Open: 0 Prev Close: 0.0001
High: 0 Low: 0
Volume: 0 Market Cap: 0M
Year High: 0.0002 Year Low: 0
Stock Technical Analysis
Overall       
Targets Six months: 0.0002    One year: 0.0002
Supports Support1: 0.0001   Support2: 0.0001
Resistances Resistance1: 0.0002    Resistance2: 0.0002 
Pivot Point 0.0002 
Moving Averages MA(5): 0.0002      MA(20): 0.0002 

MA(100): 0.0001  0     MA(250): 0.0001 
MACD MACD(12,26):       Signal(12,26,9):  
Stochastic Oscillator %K(14,3): 66.667      %D(3): 88.889 
RSI RSI(14): 32.997 
52-Week High: 0.0002  Low: 0.0001  Change(%):
Average Volume(K) 3-Month: 273629  10-Days: 25000
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is above its mid-term; and above long term moving averages. From the relationship between price and moving averages; we can see that: this stock is NEUTRAL in short-term; and BULLISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above bottom band by 8.5%; Bollinger Bands are 43.7% wider than normal.The large width of the bands suggest high volatility as compared to TCEL's normal range. The bands have been in this wide range for 8 bars. This is often a sign that the current trend may be ending.

Stoxline

Stock Chart

Top 100 stocks

Stock News
Therapy Cells Inc (TCEL) Sees The Tape Move Mid-Market
Fri, 24 Nov 2017 16:52:30 GMT

UO Reading Higher Than 60 for Therapy Cells Inc (TCEL)
Wed, 22 Nov 2017 21:33:45 GMT

Trading Radar: Checking Technicals for Therapy Cells Inc (TCEL)
Wed, 22 Nov 2017 21:33:45 GMT

Market Review: Checking the Technicals on Shares of Therapy Cells Inc (TCEL)
Fri, 17 Nov 2017 10:07:30 GMT

What's Ahead for THERAPY CELLS INCORPORATED (OTCMKTS:TCEL) After Less Shorted ...
Sat, 11 Nov 2017 18:18:06 GMT

US Stem Cell Responds to FDA's Regenerative Medicine Guidelines
Tue, 21 Nov 2017 21:56:15 GMT

Health Ministry approves pioneering placenta-cell therapy for blood disorders
Sun, 29 Oct 2017 16:43:04 GMT

Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell ...
Thu, 16 Nov 2017 13:30:00 GMT

Mustang Bio Establishes CAR T Cell Therapy Manufacturing Facility in Massachusetts
Mon, 30 Oct 2017 11:26:15 GMT

Cell therapy improves heart function, upper limb strength in duchenne muscular ...
Wed, 15 Nov 2017 16:52:30 GMT